Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05937399 · ClinicalTrials.gov registry record · NA
Project PLUS Lung Cancer Screening Promotion
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05937399 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 34 participants.
The verdict
NCT05937399, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Project PLUS is a pilot study that aims to develop and obtain preliminary feasibility and efficacy data on an enhanced risk communication approach to promote lung cancer screening (LCS) intentions among screening-eligible individuals from environmentally burdened communities. Project PLUS will combine qualitative interviews to explore subject awareness regarding lung cancer risk and air pollution, barriers to LCS, and perceptions regarding risk communication messaging, develop a health education video, and a between-subjects experiment to compare Data from this pilot will form the basis for enhanced community engagement efforts and subsequent communication research to examine the effectiveness of incorporating the involuntary air pollution risk information in risk communication interventions. The long term goal is to reduce lung cancer burden and disparities among environmentally burdened communities within and outside of Philadelphia.
Interventions
- BEHAVIORAL Control video
- BEHAVIORAL Intervention video
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2022-12-02 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05937399
The ClinicalTrials.gov registry entry for NCT05937399 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control video is the first listed.
NCT05937399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05937399 about?
NCT05937399 is a clinical study titled "Project PLUS Lung Cancer Screening Promotion". Project PLUS is a pilot study that aims to develop and obtain preliminary feasibility and efficacy data on an enhanced risk communication approach to promote lung cancer screening (LCS) intentions among screening-eligible individuals from environmentally burdened communities. Project PLUS will combi...
What is the current status of trial NCT05937399?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2022-12-02. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT05937399?
The interventions under investigation include: Control video (BEHAVIORAL), Intervention video (BEHAVIORAL).
Who is sponsoring clinical trial NCT05937399?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.